Federal regulators have approved a COVID-19 vaccine made by Moderna for some children aged 6 months through 11 years, according to an approval letter made public on July 10.
The Food and Drug Administration approved Spikevax, the vaccine, for children at least 6 months of age who are pegged as being at heightened risk for COVID-19, the FDA’s top vaccine official, Dr. Vinay Prasad, told Moderna in the missive.
“COVID-19 continues to pose a significant potential threat to children, especially those with underlying medical conditions,” Moderna CEO Stéphane Bancel said in a statement. “Vaccination can be an important tool for protecting our youngest against severe disease and hospitalization. We appreciate the FDA’s diligent scientific review and approval of Spikevax for pediatric populations at increased risk for COVID-19 disease.”…